This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|February 1, 2017
- Pharmaceutical Technology-02-01-2017
- Volume 2017 Supplement
- Issue 1
Pharmaceutical Technology, 2017 Partnerships in Outsourcing Supplement (PDF)
Click the title above to open the Pharmaceutical Technology 2017 Partnerships in Outsourcing Supplement in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Quality Metrics and CMO Agreementalmost 10 years ago
Careful, Early Cold-Chain Planning is Crucial for New Biologicsalmost 10 years ago
Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapiesalmost 10 years ago
Serialization: The Final Countdownalmost 10 years ago
Serialization Preparation Prompts Data and Business Questionsalmost 10 years ago
What Works Best in Pharma-CRO Relationships?almost 10 years ago
The Digital Supply Chain: Seizing Pharma’s Untapped Opportunityalmost 10 years ago
Zero Budget Supply Chain Risk-Monitoring and Mitigationalmost 10 years ago
Getting, and Staying, Ahead of Global Quality Demandsalmost 10 years ago
Collaborating for Efficiency and Safety in Raw Material InspectionAdvertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CPHI Pharma Award Winner: Drug Delivery, Devices, & Packaging
2
Investing in Protecting Pharma Products
3
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
4
Choosing a Connected Product Technology for Anticounterfeiting
5